CB Calidi Biotherapeutics, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Calidi Biotherapeutics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €4m. The latest transaction was reported on 16 December 2025 (Cession). Among the most active insiders: Schoeneck James A. The full history is openly available.
Buys €391,800 €16,457 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 December 2025
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
▼ Director · Executives · 12 Dec 2025
850 shares @ US$1.455 1.2% of flow Common Stock SEC:0001493152-25-028030:0
▲ Director · Executives · 21 Aug 2025
75,000 shares @ US$2.00 40.5% of flow Common Stock SEC:0001641172-25-025448:0
Canonical exit: 19 Nov 2025 (T+90) ▲ Chief Executive Officer · Executives · 21 Aug 2025
25,000 shares @ US$2.00 100.0% of flow Common Stock SEC:0001641172-25-025447:0
Canonical exit: 19 Nov 2025 (T+90) ▲ Director · Executives · 21 Aug 2025
125,000 shares @ US$2.00 93.6% of flow Common Stock SEC:0001641172-25-025446:0
Canonical exit: 19 Nov 2025 (T+90) ▲ Chief Financial Officer · Executives · 21 Aug 2025
2,500 shares @ US$2.00 100.0% of flow Common Stock SEC:0001641172-25-025445:0
Canonical exit: 19 Nov 2025 (T+90) ◆ Director · Executives · 31 Dec 2024
12,771 shares Common Stock SEC:0001493152-25-000306:0
◆ Director · Executives · 31 Dec 2024
11,684 shares Common Stock SEC:0001493152-25-000302:0
▼ CEO and Chairman of the Board · Executives · 17 Dec 2024
10,000 shares @ US$1.62 17.6% of flow Common Stock SEC:0001493152-24-050675:0
◆ CEO and Chairman of the Board · Executives · 26 Sept 2024
70,155 shares @ US$1.15 82.4% of flow Common Stock SEC:0001493152-24-038877:0
◆ Director · Executives · 28 Jun 2024
73,437 shares Common Stock SEC:0001493152-24-026113:0
◆ Director · Executives · 28 Jun 2024
79,687 shares Common Stock SEC:0001493152-24-026115:0
◆ Director · Executives · 29 Mar 2024
28,207 shares Common Stock SEC:0001493152-24-026108:0
◆ Director · Executives · 29 Mar 2024
23,783 shares Common Stock SEC:0001493152-24-026111:0
◆ Director · Executives · 28 Jun 2024
67,187 shares Common Stock SEC:0001493152-24-026117:0
◆ Director · Executives · 29 Mar 2024
25,995 shares Common Stock SEC:0001493152-24-026105:0
◇ Director · Executives · 3 Jun 2024
173,000 shares @ US$0.20 16.7% of flow Common Stock SEC:0001493152-24-022745:0
◆ Director · Executives · 18 Apr 2024
375,000 shares @ US$0.40 74.1% of flow Common Stock SEC:0001493152-24-015572:0
◆ Director · Executives · 21 Dec 2023
5,644 shares @ US$1.80 100.0% of flow Common Stock SEC:0001493152-24-001138:0
◆ Director · Executives · 21 Dec 2023
10,625 shares @ US$1.80 9.2% of flow Common Stock SEC:0001493152-24-001134:0
◆ Director · Executives · 21 Dec 2023
8,958 shares @ US$1.80 100.0% of flow Common Stock SEC:0001493152-24-001132:0
◆ Director · Executives · 21 Dec 2023
7,282 shares @ US$1.80 100.0% of flow Common Stock SEC:0001493152-24-001136:0
◆ Director · Executives · 21 Dec 2023
7,709 shares @ US$1.80 100.0% of flow Common Stock SEC:0001493152-23-046173:0
关于 Calidi Biotherapeutics, Inc. Calidi Biotherapeutics, Inc. 是一家专注于开发癌症治疗生物疗法的公司。它采用创新技术来靶向和摧毁肿瘤细胞。